Nirmal Shyam Sharma, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Transplantation | 14 | 2024 | 1309 | 2.850 |
Why?
|
Extracorporeal Membrane Oxygenation | 10 | 2023 | 1483 | 1.480 |
Why?
|
Primary Graft Dysfunction | 2 | 2022 | 112 | 0.860 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2024 | 521 | 0.810 |
Why?
|
Pseudomonas | 1 | 2022 | 124 | 0.800 |
Why?
|
Cystic Fibrosis | 2 | 2021 | 1294 | 0.770 |
Why?
|
Bronchoscopy | 2 | 2016 | 914 | 0.680 |
Why?
|
Arthritis, Psoriatic | 1 | 2022 | 219 | 0.660 |
Why?
|
Gastroesophageal Reflux | 5 | 2024 | 836 | 0.650 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 453 | 0.610 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2024 | 1361 | 0.590 |
Why?
|
Lung Injury | 2 | 2022 | 433 | 0.580 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 1049 | 0.540 |
Why?
|
Proline | 1 | 2018 | 455 | 0.540 |
Why?
|
Percussion | 1 | 2016 | 18 | 0.540 |
Why?
|
Bodily Secretions | 1 | 2016 | 28 | 0.530 |
Why?
|
Beds | 1 | 2016 | 48 | 0.520 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 757 | 0.510 |
Why?
|
Neutrophil Infiltration | 1 | 2018 | 393 | 0.510 |
Why?
|
Autoantibodies | 1 | 2024 | 2121 | 0.510 |
Why?
|
Hepatopulmonary Syndrome | 1 | 2015 | 25 | 0.490 |
Why?
|
Lung | 9 | 2024 | 10099 | 0.470 |
Why?
|
Fibrinolysis | 1 | 2014 | 331 | 0.420 |
Why?
|
Metabolome | 1 | 2020 | 1009 | 0.420 |
Why?
|
Oligopeptides | 1 | 2018 | 1194 | 0.410 |
Why?
|
Respiratory Mechanics | 1 | 2016 | 721 | 0.390 |
Why?
|
Puerperal Disorders | 1 | 2015 | 304 | 0.390 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2892 | 0.360 |
Why?
|
Neutrophils | 3 | 2023 | 3786 | 0.350 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4262 | 0.320 |
Why?
|
Shock, Septic | 1 | 2014 | 774 | 0.290 |
Why?
|
DNA | 1 | 2021 | 7214 | 0.290 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2024 | 760 | 0.290 |
Why?
|
Graft Rejection | 3 | 2024 | 4492 | 0.260 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1886 | 0.250 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2784 | 0.240 |
Why?
|
Respiratory Insufficiency | 3 | 2020 | 1240 | 0.240 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2024 | 81 | 0.230 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2726 | 0.230 |
Why?
|
Critical Care | 2 | 2022 | 2715 | 0.220 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2024 | 153 | 0.220 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11928 | 0.220 |
Why?
|
Liver Transplantation | 1 | 2015 | 2401 | 0.210 |
Why?
|
Histocompatibility Testing | 1 | 2024 | 716 | 0.210 |
Why?
|
Esophageal Motility Disorders | 1 | 2023 | 49 | 0.210 |
Why?
|
Esophagitis, Peptic | 1 | 2023 | 77 | 0.200 |
Why?
|
Interleukin-13 | 1 | 2024 | 390 | 0.200 |
Why?
|
Esophageal pH Monitoring | 4 | 2024 | 203 | 0.200 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2599 | 0.180 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 638 | 0.180 |
Why?
|
Bronchiolitis Obliterans | 1 | 2022 | 221 | 0.180 |
Why?
|
Pregnancy Complications | 1 | 2015 | 2973 | 0.180 |
Why?
|
Inflammation | 2 | 2024 | 10873 | 0.170 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3252 | 0.170 |
Why?
|
Humans | 40 | 2024 | 768166 | 0.160 |
Why?
|
Interferon Type I | 1 | 2023 | 569 | 0.160 |
Why?
|
HLA Antigens | 1 | 2024 | 1334 | 0.160 |
Why?
|
Down-Regulation | 3 | 2021 | 2937 | 0.150 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2019 | 90 | 0.150 |
Why?
|
Hypertension, Pulmonary | 2 | 2022 | 1605 | 0.150 |
Why?
|
Organoids | 1 | 2024 | 743 | 0.150 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12543 | 0.150 |
Why?
|
Paramyxoviridae Infections | 1 | 2017 | 57 | 0.140 |
Why?
|
Mutation | 2 | 2021 | 30238 | 0.140 |
Why?
|
Immunity | 1 | 2023 | 1003 | 0.140 |
Why?
|
Virus Diseases | 1 | 2023 | 724 | 0.140 |
Why?
|
Exosomes | 2 | 2018 | 422 | 0.130 |
Why?
|
Middle Aged | 14 | 2024 | 223492 | 0.130 |
Why?
|
Postoperative Complications | 2 | 2017 | 15832 | 0.130 |
Why?
|
Ribavirin | 1 | 2017 | 395 | 0.130 |
Why?
|
Reperfusion Injury | 1 | 2022 | 1039 | 0.120 |
Why?
|
Embolism, Amniotic Fluid | 1 | 2015 | 21 | 0.120 |
Why?
|
Pulmonary Fibrosis | 1 | 2019 | 506 | 0.120 |
Why?
|
Capillary Permeability | 1 | 2018 | 772 | 0.120 |
Why?
|
Carbon Monoxide Poisoning | 1 | 2015 | 65 | 0.120 |
Why?
|
Female | 21 | 2024 | 397192 | 0.120 |
Why?
|
Blood Gas Analysis | 1 | 2016 | 384 | 0.120 |
Why?
|
Drug Carriers | 1 | 2019 | 709 | 0.120 |
Why?
|
Adenosine Triphosphatases | 1 | 2019 | 842 | 0.120 |
Why?
|
Autophagy | 1 | 2022 | 1349 | 0.120 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2014 | 64 | 0.120 |
Why?
|
Rotation | 1 | 2016 | 517 | 0.120 |
Why?
|
Fibroblasts | 1 | 2024 | 4176 | 0.110 |
Why?
|
Retrospective Studies | 10 | 2024 | 81762 | 0.110 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2018 | 329 | 0.110 |
Why?
|
Gene Regulatory Networks | 2 | 2020 | 1752 | 0.110 |
Why?
|
Adult | 15 | 2024 | 223646 | 0.110 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1334 | 0.110 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4120 | 0.110 |
Why?
|
Shock | 1 | 2015 | 316 | 0.100 |
Why?
|
Multiple Organ Failure | 1 | 2015 | 388 | 0.100 |
Why?
|
Male | 16 | 2024 | 364719 | 0.100 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2015 | 452 | 0.100 |
Why?
|
Epithelial Cells | 2 | 2021 | 3703 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2024 | 3589 | 0.100 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1883 | 0.090 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 519 | 0.090 |
Why?
|
Recovery of Function | 1 | 2020 | 2981 | 0.080 |
Why?
|
Chronic Disease | 2 | 2024 | 9384 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 3049 | 0.080 |
Why?
|
Aged | 8 | 2024 | 171504 | 0.080 |
Why?
|
Influenza, Human | 1 | 2021 | 1541 | 0.080 |
Why?
|
Waiting Lists | 1 | 2014 | 779 | 0.080 |
Why?
|
Heart Failure | 3 | 2022 | 11879 | 0.080 |
Why?
|
Antiviral Agents | 2 | 2023 | 3073 | 0.080 |
Why?
|
Shock, Cardiogenic | 1 | 2015 | 711 | 0.080 |
Why?
|
Pulmonary Alveoli | 2 | 2024 | 665 | 0.080 |
Why?
|
Tissue Plasminogen Activator | 1 | 2014 | 1165 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2014 | 1443 | 0.080 |
Why?
|
Disease Progression | 2 | 2023 | 13671 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2015 | 2434 | 0.070 |
Why?
|
Blood Transfusion | 1 | 2015 | 1309 | 0.070 |
Why?
|
Pulmonary Artery | 1 | 2016 | 1946 | 0.070 |
Why?
|
Nanoparticles | 1 | 2019 | 1985 | 0.070 |
Why?
|
Heparin | 1 | 2014 | 1636 | 0.070 |
Why?
|
Heart Transplantation | 1 | 2021 | 3301 | 0.070 |
Why?
|
Oxygen | 1 | 2019 | 4270 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12840 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2016 | 1672 | 0.060 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2024 | 30 | 0.060 |
Why?
|
Anticoagulants | 2 | 2023 | 4852 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6316 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5176 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18412 | 0.060 |
Why?
|
Mice | 6 | 2022 | 82029 | 0.060 |
Why?
|
Acute Disease | 1 | 2014 | 7243 | 0.060 |
Why?
|
Pregnancy Outcome | 1 | 2015 | 2972 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2018 | 22291 | 0.050 |
Why?
|
Myofibroblasts | 1 | 2024 | 230 | 0.050 |
Why?
|
Pharyngitis | 1 | 2024 | 222 | 0.050 |
Why?
|
Hemorrhage | 1 | 2015 | 3467 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8741 | 0.050 |
Why?
|
MicroRNAs | 1 | 2018 | 3803 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39348 | 0.050 |
Why?
|
Young Adult | 2 | 2021 | 60066 | 0.050 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 561 | 0.050 |
Why?
|
Enoxaparin | 1 | 2023 | 391 | 0.050 |
Why?
|
Manometry | 1 | 2023 | 459 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2024 | 1156 | 0.040 |
Why?
|
Length of Stay | 1 | 2014 | 6498 | 0.040 |
Why?
|
Cough | 1 | 2024 | 598 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2017 | 65371 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2014 | 5349 | 0.040 |
Why?
|
Metaplasia | 1 | 2021 | 326 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22379 | 0.040 |
Why?
|
Asthma | 1 | 2018 | 6291 | 0.040 |
Why?
|
Uteroglobin | 1 | 2019 | 56 | 0.040 |
Why?
|
Animals | 6 | 2022 | 169246 | 0.040 |
Why?
|
Phosphatidylglycerols | 1 | 2018 | 35 | 0.040 |
Why?
|
Macrophages, Alveolar | 1 | 2021 | 415 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2018 | 26422 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 2018 | 222 | 0.040 |
Why?
|
Proteobacteria | 1 | 2018 | 47 | 0.040 |
Why?
|
Sphingomyelins | 1 | 2018 | 105 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2019 | 412 | 0.040 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2018 | 84 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1401 | 0.040 |
Why?
|
Critical Pathways | 1 | 2021 | 476 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1011 | 0.030 |
Why?
|
Fibroblast Growth Factor 10 | 1 | 2016 | 31 | 0.030 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2021 | 452 | 0.030 |
Why?
|
Ceramides | 1 | 2018 | 203 | 0.030 |
Why?
|
Genes, Developmental | 1 | 2016 | 38 | 0.030 |
Why?
|
HLA-DR Antigens | 1 | 2018 | 609 | 0.030 |
Why?
|
Syndrome | 1 | 2022 | 3272 | 0.030 |
Why?
|
United States | 3 | 2023 | 73039 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2023 | 12077 | 0.030 |
Why?
|
Hyperoxia | 1 | 2018 | 261 | 0.030 |
Why?
|
Particle Size | 1 | 2019 | 1649 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2018 | 1134 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 15597 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2486 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26379 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2024 | 6526 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1679 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 30256 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2018 | 2678 | 0.030 |
Why?
|
Adolescent | 1 | 2021 | 89169 | 0.020 |
Why?
|
Tobacco Smoke Pollution | 1 | 2018 | 828 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2016 | 771 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2018 | 1506 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4568 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2016 | 59629 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 2219 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 5505 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4030 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1996 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23645 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2019 | 3139 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4146 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74944 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54926 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 21538 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2019 | 10474 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11095 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16726 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10632 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9538 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2018 | 11669 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8748 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15948 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18349 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20227 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 30010 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 40218 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2016 | 20760 | 0.010 |
Why?
|